• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚胺培南(N-甲酰亚胺基硫霉素)对肠球菌的比较活性及其与氨基糖苷类药物的相互作用。

Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.

作者信息

Aznar J, García Iglesias M C, Perea E J

出版信息

J Antimicrob Chemother. 1984 Feb;13(2):129-32. doi: 10.1093/jac/13.2.129.

DOI:10.1093/jac/13.2.129
PMID:6423613
Abstract

Activity of imipenem (N-formimidoyl thienamycin, ampicillin and vancomycin against 27 Streptococcus faecalis and 5 Str. faecium was determined. Also evaluated were the interactions of imipenem, ampicillin and vancomycin with streptomycin or amikacin or sissomicin. Imipenem showed the most inhibitory activity against Str. faecalis with MIC50 and MIC90 values 0.5 and 2 mg/l respectively, Str. faecium strains were less susceptible to imipenem with MIC50/MIC90 values of 2/16 mg/l. Imipenem showed good bactericidal activity against both groups of strains with MBC50/MBC90 values of 1/4 and 4/16 mg/l respectively. The most favourable interactions (synergy and addition) of imipenem were with streptomycin (72.2%) and sissomicin (53.2%). Combinations containing amikacin were the least favourable. Similar results were obtained with these combinations against Str. faecium.

摘要

测定了亚胺培南(N-甲酰亚胺硫霉素)、氨苄西林和万古霉素对27株粪肠球菌和5株屎肠球菌的活性。还评估了亚胺培南、氨苄西林和万古霉素与链霉素、阿米卡星或西索米星的相互作用。亚胺培南对粪肠球菌的抑制活性最强,其MIC50和MIC90值分别为0.5和2mg/L,屎肠球菌菌株对亚胺培南的敏感性较低,MIC50/MIC90值为2/16mg/L。亚胺培南对两组菌株均显示出良好的杀菌活性,MBC50/MBC90值分别为1/4和4/16mg/L。亚胺培南最有利的相互作用(协同和相加)是与链霉素(72.2%)和西索米星(53.2%)。含阿米卡星的组合最不利。这些组合对屎肠球菌也得到了类似的结果。

相似文献

1
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.亚胺培南(N-甲酰亚胺基硫霉素)对肠球菌的比较活性及其与氨基糖苷类药物的相互作用。
J Antimicrob Chemother. 1984 Feb;13(2):129-32. doi: 10.1093/jac/13.2.129.
2
Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.链霉素联合氨苄西林、环丙沙星、亚胺培南、哌拉西林或万古霉素对粪肠球菌和屎肠球菌菌株的比较杀菌活性及抗生素后效应
Chemotherapy. 1988;34(3):229-34. doi: 10.1159/000238574.
3
Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.N-甲酰亚胺硫霉素与庆大霉素和阿米卡星对粪肠球菌的协同作用。
Antimicrob Agents Chemother. 1983 Feb;23(2):245-7. doi: 10.1128/AAC.23.2.245.
4
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.肠球菌和单核细胞增生李斯特菌对单独使用及与氨基糖苷类联合使用的N-亚胺基噻烯霉素的敏感性。
Antimicrob Agents Chemother. 1981 May;19(5):789-93. doi: 10.1128/AAC.19.5.789.
5
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.亚胺培南或青霉素G与氨基糖苷类药物对感染性心内膜炎患者分离出的肠球菌的协同作用。
Antimicrob Agents Chemother. 1984 Dec;26(6):909-12. doi: 10.1128/AAC.26.6.909.
6
Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.N-甲酰亚胺基硫霉素与庆大霉素或妥布霉素对肠球菌的协同作用。
Antimicrob Agents Chemother. 1982 Dec;22(6):1082-3. doi: 10.1128/AAC.22.6.1082.
7
N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.N-甲酰亚胺基硫霉素与诺氟沙星对多重耐药铜绿假单胞菌菌株的作用。体外联合活性及与其他14种抗生素的比较
Drugs Exp Clin Res. 1985;11(4):247-51.
8
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.粪肠球菌和屎肠球菌的鉴定以及新型抗菌剂的药敏研究。
J Clin Microbiol. 1987 May;25(5):787-90. doi: 10.1128/jcm.25.5.787-790.1987.
9
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.克林沙星与其他抗菌药物对万古霉素敏感和耐药肠球菌的体外比较活性。
Chemotherapy. 1996 Jul-Aug;42(4):235-9. doi: 10.1159/000239449.
10
In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.
Drugs Exp Clin Res. 1987;13(8):479-81.

引用本文的文献

1
In vitro activity of imipenem--a review.亚胺培南的体外活性——综述
Eur J Clin Microbiol. 1984 Oct;3(5):456-62. doi: 10.1007/BF02017375.
2
Pharmacokinetics of imipenem-cilastatin in neonates.亚胺培南-西司他丁在新生儿中的药代动力学。
Antimicrob Agents Chemother. 1985 Apr;27(4):431-5. doi: 10.1128/AAC.27.4.431.
3
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
4
In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.亚胺培南对肠球菌和葡萄球菌的体外活性以及与替考拉宁、磷霉素和利福平有高协同率的证据。
Antimicrob Agents Chemother. 1986 Nov;30(5):813-5. doi: 10.1128/AAC.30.5.813.